Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials
Background Eosinophils are involved in the pathogenesis of atopic dermatitis (AD).Objective This post-hoc analysis evaluated the effect of stapokibart on blood eosinophil counts in moderate-to-severe AD patients.Methods The phase II AD002 trial (n = 120) randomly assigned patients to stapokibart 300...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2026-12-01
|
| Schriftenreihe: | Journal of Dermatological Treatment |
| Schlagworte: | |
| Online-Zugang: | https://www.tandfonline.com/doi/10.1080/09546634.2026.2670906 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
